479 results
Tricuspid valve disease: state-of-the-art
23 Nov 2021 – From PCR London Valves 2021
Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...
Tricuspid valve disease: guidelines and beyond
23 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...
Transcatheter tricuspid valve interventions: the future
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...
Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential
22 Nov 2021 – From PCR London Valves 2021
Plunge into the universe of mitral and tricuspid in this PCR London Valves 2021 session, and learn how to optimize patient selection and tailor our procedural strategy, understand how to optimize patient outcomes with dedicated devices, and experience how to maximize the use of the G4...
From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options
22 Nov 2021 – From PCR London Valves
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...
Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation
22 Nov 2021 – From PCR London Valves 2021
In this session broadcast at PCR London Valves 2021, discuss and explore transcatheter therapies for the treatment of tricuspid regurgitation and their clinical impact, analyze the recorded live case of an 81-year-old female patient from Leipzig, and discover the potential of transcatheter replacement technologies in the...
Tricuspid valve disease: diagnosis and treatment selection
22 Nov 2021 – From PCR London Valves 2021
Presented during PCR London Valves 2021, view the case of an 85-year-old patient with hypertension, diabetes, and dyslipidemia, who has permanent atrial fibrillation and renal failure, but no left-sided valvular heart disease and follow the debates around which treatments to adopt!
Transcatheter tricuspid valve interventions: optimal technique and procedural refinement
22 Nov 2021 – From PCR London Valves 2021
With this session from PCR London Valves 2021, learn more about a procedure that is becoming increasingly popular and reproducible: the transcatheter tricuspid valve intervention. Pre-procedural planning, successful management of major complications, and requirements for implementing a program at your center are key topics.
Transcatheter tricuspid valve interventions: prevention of complications and their management
22 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 if you want to find out more about the complications you may encounter during transcatheter tricuspid valve procedures, learn more about how to schedule and prepare for these interventions to avoid complications, and get more tips and tricks...
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
